FENNEC PHARMACEUTICALS INC (FRX.CA) Stock Analyst Earnings Estimates
TSX:FRX - Toronto Stock Exchange - CA31447P1009 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.54M | 21.252M 1,280.00% | 47.538M 123.69% | 47.94M 0.85% | 74.382M 55.16% | 94.948M 27.65% | 126.79M 33.54% | 172.76M 36.26% | 175.69M 1.70% | 181.53M 3.32% | 183.14M 0.89% | |
| EBITDA YoY % growth | N/A | N/A | N/A 216.67% | 17.646M 147.14% | 30.906M 75.14% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -22.59M -31.18% | -13M 42.45% | 2.57M 119.77% | 6.171M 140.12% | 25.375M 311.20% | 45.884M 80.82% | 71.907M 56.71% | 114.02M 58.57% | 113.14M -0.77% | 118.71M 4.92% | 120.29M 1.33% | |
| Operating Margin | -1,466.88% | -61.17% | 5.41% | 12.87% | 34.11% | 48.33% | 56.71% | 66.00% | 64.40% | 65.39% | 65.68% | |
| EPS YoY % growth | -0.90 -34.33% | -0.61 32.22% | 0.00 100.00% | 0.17 308,694,732,858,483,400.00% | 0.84 391.67% | 1.52 79.98% | 2.39 57.40% | 3.57 49.57% | 3.52 -1.43% | 3.59 1.88% | 3.55 -1.00% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 81.64% | 0.10 148.57% | 0.15 344.80% | 0.11 374.76% |
| Revenue Q2Q % growth | 9.707M 33.67% | 13.589M 94.85% | 15.729M 98.47% | 15.529M 77.45% |
| EBITDA Q2Q % growth | 918K 125.00% | 2.448M 1,300.00% | 13.464M 2,540.00% | 3.366M 353.85% |
| EBIT Q2Q % growth | -685.44K 86.40% | 3.152M 160.62% | 4.547M 588.92% | 3.439M 524.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.04 -108.51% | -0.09 | 0.05 | 55.84% |
| Q4 2024 Q2Q % growth | -0.06 40.00% | 0.17 | -0.23 | -135.44% |
| Q3 2024 Q2Q % growth | -0.21 -200.00% | -0.09 | -0.12 | -128.76% |
| Q2 2024 Q2Q % growth | -0.20 4.76% | -0.03 | -0.17 | -539.32% |
| Q1 2024 Q2Q % growth | 0.47 304.35% | 0.27 | 0.20 | 75.87% |
| Q4 2023 Q2Q % growth | -0.10 61.54% | -0.02 | -0.08 | -400.20% |
| Q3 2023 Q2Q % growth | -0.07 77.42% | -0.12 | 0.05 | 42.81% |
| Q2 2023 Q2Q % growth | -0.21 -10.53% | -0.16 | -0.05 | -31.55% |
| Q1 2023 Q2Q % growth | -0.23 -64.29% | -0.21 | -0.02 | -7.48% |
| Q4 2022 Q2Q % growth | -0.26 -44.44% | -0.27 | 0.01 | 3.75% |
| Q3 2022 Q2Q % growth | -0.31 -93.75% | -0.19 | -0.12 | -67.29% |
| Q2 2022 Q2Q % growth | -0.19 -26.67% | -0.14 | -0.05 | -36.30% |
| Q1 2022 Q2Q % growth | -0.14 22.22% | -0.14 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.18 -38.46% | 0.76 | -0.94 | -123.61% |
| Q3 2021 Q2Q % growth | -0.16 33.33% | -0.17 | 0.01 | 7.73% |
| Q2 2021 Q2Q % growth | -0.15 28.57% | -0.19 | 0.04 | 21.78% |
| Q1 2021 Q2Q % growth | -0.18 5.26% | -0.13 | -0.05 | -35.75% |
| Q4 2020 Q2Q % growth | -0.13 27.78% | -0.19 | 0.06 | 32.92% |
| Q3 2020 Q2Q % growth | -0.24 -166.67% | -0.19 | -0.05 | -23.84% |
| Q2 2020 Q2Q % growth | -0.21 12.50% | -0.18 | -0.03 | -16.53% |
| Q1 2020 Q2Q % growth | -0.19 -46.15% | -0.19 | 0.00 | 0.21% |
| Q4 2019 Q2Q % growth | -0.18 | -0.13 | -0.05 | -35.75% |
| Q3 2019 Q2Q % growth | -0.09 | -0.20 | 0.11 | 55.88% |
| Q2 2019 Q2Q % growth | -0.24 | -0.14 | -0.10 | -72.16% |
| Q1 2019 Q2Q % growth | -0.13 | -0.16 | 0.03 | 16.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 8.751M -65.52% | 8.345M | 406K | 4.87% |
| Q4 2024 Q2Q % growth | 7.925M -18.59% | 17.051M | -9.126M | -53.52% |
| Q3 2024 Q2Q % growth | 6.974M 12.77% | 9.162M | -2.188M | -23.88% |
| Q2 2024 Q2Q % growth | 7.262M 118.41% | 11.269M | -4.007M | -35.56% |
| Q1 2024 Q2Q % growth | 25.377M 1,413.24% | 19.254M | 6.123M | 31.80% |
| Q4 2023 Q2Q % growth | 9.735M 532.14% | 8.843M | 892K | 10.09% |
| Q3 2023 Q2Q % growth | 6.184M | 5.443M | 741K | 13.61% |
| Q2 2023 Q2Q % growth | 3.325M | 3.81M | -485K | -12.73% |
| Q1 2023 Q2Q % growth | 1.677M | 1.884M | -207K | -10.99% |
| Q4 2022 Q2Q % growth | 1.54M | 759.727K | 780.273K | 102.70% |
| Q4 2021 Q2Q % growth | -100.00% | 34M | -34M | -100.00% |
| Q3 2020 Q2Q % growth | 484.5K | -484.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 46.43% | 0% | 152.25% |
| Revenue | 0% | 1.74% | 0% | -1.79% |